市场调查报告书
商品编码
1394972
裸金属支架市场规模- 按产品(自扩张式、球囊扩张式)、材料类型(不銹钢、钴铬合金、镍钛合金)、应用(冠状动脉、外周动脉)、最终用途(医院、ASC)和预测,2023 年- 2032Bare Metal Stents Market Size - By Product (Self-expandable, Balloon Expandable), Material Type (Stainless Steel, Cobalt-Chromium Alloy, Nitinol), Application (Coronary, Peripheral), End-use (Hospitals, ASCs) & Forecast, 2023 - 2032 |
在由顶尖研究人员主导的旨在理解和评估这些设备的广泛研究工作的推动下,全球裸金属支架市场在 2023 年至 2032 年间CAGR将达到 2.8%。随着研究加深对裸金属支架功效和限制的了解,该市场出现了激增。
例如,2023年6月,WL Gore & Associates (Gore)启动了Gore VBX FORWARD临床研究,以评估VBX覆膜支架与裸金属支架在治疗复杂性髂闭塞性疾病的有效性。对性能、耐用性和相容性的不懈追求推动了这一需求。随着领先的研究人员深入研究优化设计和材料成分,他们的发现推动了裸金属支架的市场需求,塑造了裸金属支架在现代医疗实践中的演变和应用。
整个裸金属支架行业根据产品、应用和地区进行分类。
自膨胀支架领域将在 2023 年至 2032 年期间经历重大发展。这些先进的支架具有多功能性和适应性,可适应复杂的解剖结构。凭藉其自扩张能力,这些支架可提供精确的部署和安全的血管支撑。随着医生寻求高效、微创的解决方案,对自膨胀裸金属支架的需求激增。它们适应不同血管尺寸和复杂性的能力标誌着一个关键的转变,推动裸金属支架市场的成长轨迹,以追求改善患者的治疗结果和提高手术效果。
2023年至2032年,週边动脉段的复合CAGR将显着。随着週边动脉疾病的增加,裸金属支架将成为恢復血流和提供结构支撑的重要工具。随着医疗介入优先考虑微创手术,对这些支架的需求不断增加。它们加强狭窄动脉并保持血管通畅的能力满足了周边动脉介入治疗的关键需求,反映了裸金属支架市场因可靠和高效的治疗选择而扩张。
亚太地区裸金属支架市场将在2023年至2032年呈现出值得称讚的CAGR。随着人口的迅速增长和心血管疾病患病率的增加,迫切需要有效的治疗解决方案。
裸金属支架在这种情况下发挥关键作用,为动脉疾病管理提供了经济高效且可靠的选择。随着该地区注重先进的医疗干预措施,对这些支架的需求激增,反映出它们在解决整个亚太地区心血管健康挑战方面的关键作用。例如,2023 年 4 月,印度在批发价格指数 (WPI) 修订后提高了冠状动脉支架的价格上限,包括裸金属支架和药物洗脱支架。根据国家药品定价局 (NPPA) 的指令,裸金属支架的最高价格调整为 10,509 卢比。
Global Bare Metal Stents Market will witness 2.8% CAGR between 2023 and 2032, driven by extensive research endeavors aimed at comprehending and appraising these devices, spearheaded by top researchers. As studies deepen the understanding of bare metal stents' efficacy and limitations, this market witnesses a surge.
For instance, in June 2023, W. L. Gore & Associates (Gore) initiated the Gore VBX FORWARD Clinical Study to evaluate the effectiveness of the VBX Stent Graft compared to bare metal stenting in treating complex iliac occlusive disease. The relentless pursuit of insights into their performance, durability, and compatibility fuels this demand. As leading researchers delve deeper into optimizing design and material compositions, their findings propel the bare metal stents market demand, shaping the evolution and applications of bare metal stents in modern medical practices.
The overall Bare Metal Stents Industry is classified based on product, application, and region.
Self-expandable stent segment will undergo significant development from 2023 to 2032. These advanced stents offer versatility and adaptability, catering to intricate anatomical structures. With their self-expanding capability, these stents provide precise deployment and secure vessel support. As medical practitioners seek efficient and minimally invasive solutions, the demand for self-expanding bare metal stents skyrockets. Their ability to conform to diverse vessel sizes and complexities marks a pivotal shift, propelling the bare metal stents market growth trajectory in the pursuit of improved patient outcomes and enhanced procedural efficacy.
Peripheral artery segment will register a noteworthy CAGR from 2023 to 2032. With peripheral artery diseases on the rise, bare metal stents serve as vital tools in restoring blood flow and providing structural support. As medical interventions prioritize minimally invasive procedures, the demand for these stents escalates. Their ability to reinforce narrowed arteries and maintain vessel patency addresses critical needs in peripheral artery interventions, reflecting the bare metal stents market expansion from reliable and efficient treatment options.
Asia Pacific bare metal stents market will showcase a commendable CAGR from 2023 to 2032. With a burgeoning population and increased prevalence of cardiovascular diseases, there's a pressing need for effective treatment solutions.
Bare metal stents play a pivotal role in this scenario, offering cost-effective and reliable options for artery disease management. As the region focuses on advanced medical interventions, the demand for these stents soars, reflecting their crucial role in addressing cardiovascular health challenges across Asia Pacific. For instance, in April 2023, in India, the price caps on coronary stents, covering both bare metal and drug-eluting variants, were raised following the Wholesale Price Index (WPI) revision. As per the directive from the National Pharmaceutical Pricing Authority (NPPA), the maximum price for bare metal stents was adjusted to Rs 10,509.